**Cardiology**

[50] Pryer NK, Lee LB, Zadovaskaya R, Yu X, Sukbuntherng J, Cherrington JM, London CA. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell

[51] Le Cesne A, Blay J, Bui BN, Bouché O, Adenis A, Domont J, Cioffi A, Ray‐Coquard I, Lassau N, Bonvalot S. Phase II study of oral masitinib mesylate in imatinib‐naive patients with locally advanced or metastatic gastro‐intestinal stromal tumour (GIST).

**9**:5729–5734.

Eur J Cancer. 2010;**46**:1344–1351. doi:10.1016/j.ejca.2010.02.014

tumors. Clin Cancer Res. 2003;

92 Canine Medicine - Recent Topics and Advanced Research
